Literature DB >> 35483372

In situ identification of cellular drug targets in mammalian tissue.

Zhengyuan Pang1, Michael A Schafroth2, Daisuke Ogasawara2, Yu Wang1, Victoria Nudell1, Neeraj K Lal1, Dong Yang1, Kristina Wang1, Dylan M Herbst3, Jacquelyn Ha3, Carlos Guijas3, Jacqueline L Blankman3, Benjamin F Cravatt2, Li Ye4.   

Abstract

The lack of tools to observe drug-target interactions at cellular resolution in intact tissue has been a major barrier to understanding in vivo drug actions. Here, we develop clearing-assisted tissue click chemistry (CATCH) to optically image covalent drug targets in intact mammalian tissues. CATCH permits specific and robust in situ fluorescence imaging of target-bound drug molecules at subcellular resolution and enables the identification of target cell types. Using well-established inhibitors of endocannabinoid hydrolases and monoamine oxidases, direct or competitive CATCH not only reveals distinct anatomical distributions and predominant cell targets of different drug compounds in the mouse brain but also uncovers unexpected differences in drug engagement across and within brain regions, reflecting rare cell types, as well as dose-dependent target shifts across tissue, cellular, and subcellular compartments that are not accessible by conventional methods. CATCH represents a valuable platform for visualizing in vivo interactions of small molecules in tissue.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  click chemistry; covalent inhibitor; drug distribution; drug target engagement; molecular imaging; target identification

Mesh:

Year:  2022        PMID: 35483372      PMCID: PMC9106931          DOI: 10.1016/j.cell.2022.03.040

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   66.850


  54 in total

1.  A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes.

Authors:  Vsevolod V Rostovtsev; Luke G Green; Valery V Fokin; K Barry Sharpless
Journal:  Angew Chem Int Ed Engl       Date:  2002-07-15       Impact factor: 15.336

2.  Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474.

Authors:  Annelot C M van Esbroeck; Antonius P A Janssen; Armand B Cognetta; Daisuke Ogasawara; Guy Shpak; Mark van der Kroeg; Vasudev Kantae; Marc P Baggelaar; Femke M S de Vrij; Hui Deng; Marco Allarà; Filomena Fezza; Zhanmin Lin; Tom van der Wel; Marjolein Soethoudt; Elliot D Mock; Hans den Dulk; Ilse L Baak; Bogdan I Florea; Giel Hendriks; Luciano De Petrocellis; Herman S Overkleeft; Thomas Hankemeier; Chris I De Zeeuw; Vincenzo Di Marzo; Mauro Maccarrone; Benjamin F Cravatt; Steven A Kushner; Mario van der Stelt
Journal:  Science       Date:  2017-06-09       Impact factor: 47.728

3.  Third-generation in situ hybridization chain reaction: multiplexed, quantitative, sensitive, versatile, robust.

Authors:  Harry M T Choi; Maayan Schwarzkopf; Mark E Fornace; Aneesh Acharya; Georgios Artavanis; Johannes Stegmaier; Alexandre Cunha; Niles A Pierce
Journal:  Development       Date:  2018-06-26       Impact factor: 6.868

4.  Chemical Landscape for Tissue Clearing Based on Hydrophilic Reagents.

Authors:  Kazuki Tainaka; Tatsuya C Murakami; Etsuo A Susaki; Chika Shimizu; Rie Saito; Kei Takahashi; Akiko Hayashi-Takagi; Hiroshi Sekiya; Yasunobu Arima; Satoshi Nojima; Masako Ikemura; Tetsuo Ushiku; Yoshihiro Shimizu; Masaaki Murakami; Kenji F Tanaka; Masamitsu Iino; Haruo Kasai; Toshikuni Sasaoka; Kazuto Kobayashi; Kohei Miyazono; Eiichi Morii; Tadashi Isa; Masashi Fukayama; Akiyoshi Kakita; Hiroki R Ueda
Journal:  Cell Rep       Date:  2018-08-21       Impact factor: 9.423

5.  Sulfated ligands for the copper(I)-catalyzed azide-alkyne cycloaddition.

Authors:  Wei Wang; Senglian Hong; Andrew Tran; Hao Jiang; Rebecca Triano; Yi Liu; Xing Chen; Peng Wu
Journal:  Chem Asian J       Date:  2011-09-08

6.  Activity-based protein profiling in vivo using a copper(i)-catalyzed azide-alkyne [3 + 2] cycloaddition.

Authors:  Anna E Speers; Gregory C Adam; Benjamin F Cravatt
Journal:  J Am Chem Soc       Date:  2003-04-23       Impact factor: 15.419

7.  O-hydroxyacetamide carbamates as a highly potent and selective class of endocannabinoid hydrolase inhibitors.

Authors:  Micah J Niphakis; Douglas S Johnson; T Eric Ballard; Cory Stiff; Benjamin F Cravatt
Journal:  ACS Chem Neurosci       Date:  2011-10-10       Impact factor: 4.418

8.  Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.

Authors:  John C Byrd; Richard R Furman; Steven E Coutre; Ian W Flinn; Jan A Burger; Kristie A Blum; Barbara Grant; Jeff P Sharman; Morton Coleman; William G Wierda; Jeffrey A Jones; Weiqiang Zhao; Nyla A Heerema; Amy J Johnson; Juthamas Sukbuntherng; Betty Y Chang; Fong Clow; Eric Hedrick; Joseph J Buggy; Danelle F James; Susan O'Brien
Journal:  N Engl J Med       Date:  2013-06-19       Impact factor: 91.245

9.  Activity-based probes for studying the activity of flavin-dependent oxidases and for the protein target profiling of monoamine oxidase inhibitors.

Authors:  Joanna M Krysiak; Johannes Kreuzer; Peter Macheroux; Albin Hermetter; Stephan A Sieber; Rolf Breinbauer
Journal:  Angew Chem Int Ed Engl       Date:  2012-06-11       Impact factor: 15.336

10.  Discovery of a Potent, Long-Acting, and CNS-Active Inhibitor (BIA 10-2474) of Fatty Acid Amide Hydrolase.

Authors:  László E Kiss; Alexandre Beliaev; Humberto S Ferreira; Carla P Rosa; Maria João Bonifácio; Ana I Loureiro; Nuno M Pires; P Nuno Palma; Patrício Soares-da-Silva
Journal:  ChemMedChem       Date:  2018-09-11       Impact factor: 3.466

View more
  1 in total

1.  Illuminating spatial pharmacology with in situ drug imaging.

Authors:  Zhengyuan Pang; Li Ye
Journal:  Clin Transl Med       Date:  2022-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.